Sage Journals: Discover world-class research

Retricted access

Research article

First published 1994-6

Long-term infusional and oral therapy with pentoxiphylline in peripheral vasculopathy: A 3-year follow-up

C. Allegra, A. Carlizza, A. Mari [...]

Clinical Hemorheology and Microcirculation

Retricted access

Research article

First published 1997-1

Infusional Therapy

Edmondo Terzoli

Tumori Journal

Retricted access

Research article

First published 2010-05

Pharmacoeconomic Aspects of FOLFIRI or FOLFOX Regimens Administered with a Fully Ambulatory Pump Compared to the Day Hospital Setting

Marco Tampellini

Tumori Journal

Retricted access

Research article

First published 2007-03

Sphincter Preservation in Four Consecutive Phase II Studies of Preoperative Chemoradiation: Analysis of 247 T3 Rectal Cancer Patients

Maria Antonietta Gambacorta, Vincenzo Valentini, Claudio Coco [...]

Tumori Journal

Retricted access

Research article

First published 2002-6

New face for a familiar friend: the deGramont regimen in the treatment of metastatic colorectal cancer given as an outpatient: a feasibility study

Michelle Rowe, Juan W Valle, Ric Swindell [...]

Journal of Oncology Pharmacy Practice

Retricted access

Announcement

First published 2005-1

Diagnosis and Uretheroscopy Undeleayed Therapy of Complicated Uretheral Calculosis

G. Passavanti, V. Pizzuti, R. Paolini [...]

Urologia Journal

Retricted access

Case report

First published 2018-10

Interstitial lung disease following FOLFOX + FOLFIRI and bevacizumab therapy associated with leucovorin: A case report

Satoru Mitsuboshi, Hiromi Kozakai, Hitoshi Yamada [...]

Journal of Oncology Pharmacy Practice

Retricted access

Research article

First published 2004-9

Rapid Tumor Lysis Syndrome in a Patient with Metastatic Colon Cancer as a Complication of Treatment with 5-Fluorouracil/Leucoverin and Irinotecan

Ilhan Oztop, Binnaz Demirkan, Arzu Yaren [...]

Tumori Journal

Retricted access

Research article

First published 2006-6

A Complication-Free Course Ensures a Survival Advantage in Patients after Regional Therapy for Metastatic Colorectal Cancer

Dana Osborne, Effie Pappas, Gerald Alexander [...]

The American Surgeon™

Retricted access

Research article

First published 2011-06

Should High-Dose Interleukin-2 Still be the Preferred Treatment for Patients with Metastatic Renal Cell Cancer?

Robert O. Dillman, Neil M. Barth, Louis A. VanderMolen [...]

Cancer Biotherapy and Radiopharmaceuticals

Search results